No Evidence for Drug-Specific Activation of Circulating T Cells from Patients with HLA-DRB1*07:01-Restricted Lapatinib-Induced Liver Injury. (2016)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.chemrestox.6b00400
PubMed Identifier: 27989141
Publication URI: http://europepmc.org/abstract/MED/27989141
Type: Journal Article/Review
Volume: 29
Parent Publication: Chemical research in toxicology
Issue: 12
ISSN: 0893-228X